Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Yunfei Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0725-7258; OpenAlex author ID A5100704151. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 7

  1. A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgery. First author DOI 10.1080/02656736.2024.2398557↗
  2. Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNA-based diagnostic model. Co-author DOI 10.3389/fonc.2023.1244578↗
  3. The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling. Co-author DOI 10.1080/15384047.2022.2054257↗
  4. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1016/j.pan.2021.01.011↗
  5. NR2F1-AS1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Competing Endogenous RNA Regulatory Network Constructed by Sponging miRNA-146a-5p/miRNA… First author DOI 10.3389/fcell.2021.736980↗
  6. CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1. Co-author DOI 10.2147/cmar.s239326↗
  7. Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF. Co-author DOI 10.2147/ott.s222703↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongwei Zhu · 4 shared papers, 2020–2022 · strength 0.60
  2. Xiao Yu · 2 shared papers, 2021–2024 · strength 0.40
  3. Xiao Yu · 2 shared papers, 2021–2022 · strength 0.30
  4. Wenzhe Gao · 2 shared papers, 2021–2022 · strength 0.30
  5. Guangping Tu · 1 shared paper, 2024 · strength 0.23
  6. Li Yu · 1 shared paper, 2024 · strength 0.23
  7. Qiuling Shi · 1 shared paper, 2024 · strength 0.23
  8. Dong Luo · 1 shared paper, 2021 · strength 0.17
  9. Lai Jiang · 1 shared paper, 2023 · strength 0.17
  10. Hao Chi · 1 shared paper, 2023 · strength 0.17
  11. Shengke Zhang · 1 shared paper, 2023 · strength 0.17
  12. Guanhu Yang · 1 shared paper, 2023 · strength 0.17
  13. Duo Han · 1 shared paper, 2022 · strength 0.16
  14. Xiao Yu · 1 shared paper, 2020 · strength 0.13
  15. Hongwei Zhu · 1 shared paper, 2019 · strength 0.11
  16. Yu Pei Xiao · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.